INTERACTION OF TRIAZOLAM AND KETOCONAZOLE

被引:19
作者
GREENBLATT, DJ [1 ]
VONMOLTKE, LL [1 ]
HARMATZ, JS [1 ]
HARREL, LM [1 ]
TOBIAS, S [1 ]
SHADER, RI [1 ]
WRIGHT, CE [1 ]
机构
[1] UPJOHN CO,KALAMAZOO,MI
来源
LANCET | 1995年 / 345卷 / 8943期
关键词
D O I
10.1016/S0140-6736(95)90193-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:191 / 191
页数:1
相关论文
共 5 条
[1]  
ALBENGRES E, 1992, INT J CLIN PHARM TH, V30, P555
[2]   TERFENADINE-KETOCONAZOLE INTERACTION - PHARMACOKINETIC AND ELECTROCARDIOGRAPHIC CONSEQUENCES [J].
HONIG, PK ;
WORTHAM, DC ;
ZAMANI, K ;
CONNER, DP ;
MULLIN, JC ;
CANTILENA, LR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (12) :1513-1518
[3]   MIDAZOLAM SHOULD BE AVOIDED IN PATIENTS RECEIVING THE SYSTEMIC ANTIMYCOTICS KETOCONAZOLE OR ITRACONAZOLE [J].
OLKKOLA, KT ;
BACKMAN, JT ;
NEUVONEN, PJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (05) :481-485
[4]  
VONMOLTKE LL, 1994, BRIT J CLIN PHARMACO, V38, P23
[5]  
VONMOLTKE LL, 1994, CLIN PHARMACOL THER, V55, P179